Skip to main content
SpringerLink
Log in

Update on epidemiology, diagnosis, and treatment of pertussis

  • Editorial
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

AlthoughBordetella pertussis was identified as the causative organism of whooping cough in 1906 (1), numerous questions regarding epidemiology, diagnosis, treatment, and prevention of this disease remain unanswered. Widespread immunization has drastically reduced the prevalence of pertussis in many countries, but epidemics still occur, even in well-immunized communities (2, 3), which explains the continued interest in this old disease.

This editorial will focus on some recent developments in the areas of epidemiology, diagnosis, and treatment of pertussis; it is not, however, intended as a comprehensive review of these fields.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bordet J, Gengou O: Le microbe de la coqueluche. Annales de l'Institut Pasteur 1906, 20: 731–741.

    Google Scholar 

  2. Farizo KM, Cochi SL, Zell ER, Brink EW, Wassilak SG, Patriarca PA: Epidemiological features of pertussis in the United States, 1980–1989. Clinical Infectious Diseases 1992, 14: 708–719.

    Google Scholar 

  3. Christie CDC, Marx ML, Marchant CD, Reising SF: The 1993 epidemic of pertussis in Cincinnati. New England Journal of Medicine 1994, 331: 16–21.

    Google Scholar 

  4. Thomas MG: Epidemiology of pertussis. Reviews of Infectious Diseases 1989, 11: 255–262.

    Google Scholar 

  5. Isacson J, Trollfors B, Taranger J, Zackrisson G, Lagergard T: How common is whooping cough in a nonvaccinating country? Pediatric Infectious Disease Journal 1993, 12: 284–288.

    Google Scholar 

  6. Jenkinson D: Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. British Medical Journal 1988, 296: 612–614.

    Google Scholar 

  7. Mink CM, Cherry JD, Christenson P, Lewis K, Pineda E, Shlian D, Dawson JA, Blumberg DA: A search forBordetella pertussis infection in university students. Clinical Infectious Diseases 1992, 14: 464–471.

    Google Scholar 

  8. Deville JG, Cherry JD, Christenson PD, Pineda E, Leach CT, Kuhls TL, Viker S: Frequency of unrecognizedBordetella pertussis infections in adults. Clinical Infectious Diseases 1995, 21: 639–642.

    Google Scholar 

  9. Mortimer EA: Pertussis and its prevention: a family affair. Journal of Infectious Diseases 1990, 161: 473–479.

    Google Scholar 

  10. Wirsing von König CH, Tacken A, Finger H: Keuchhusten bei Erwachsenen. Deutsche Medizinische Wochenschrift 1991, 116: 649–653.

    Google Scholar 

  11. Postels-Multani S, Schmitt HJ, Wirsing von König CH, Bock HL, Bogaerts H: Symptoms and complications of pertussis in adults. Infection 1995, 23: 139–142.

    Google Scholar 

  12. Heininger U, Stehr K, Schmitt-Grohé S, Lorenz C, Rost R, Christenson PD, Überall M, Cherry JD: Clinical characteristics of illness caused byBordetella parapertussis compared with illness caused byBordetella pertussis. Pediatric Infectious Disease Journal 1994, 13: 306–309.

    Google Scholar 

  13. Wirsing von König CH, Finger H: Role of pertussis toxin in causing symptoms ofBordetella parapertussis infection. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 455–458.

    Google Scholar 

  14. Hoppe JE: Methods for isolation ofBordetella pertussis from patients with whooping cough. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7: 616–620.

    Google Scholar 

  15. Hallander HO, Reizenstein E, Renemar B, Rasmuson G, Mardin L, Olin P: Comparison of nasopharyngeal aspirates with swabs for culture ofBordetella pertussis. Journal of Clinical Microbiology 1993, 31: 50–52.

    Google Scholar 

  16. Regan J, Lowe F: Enrichment medium for the isolation ofBordetella. Journal of Clinical Microbiology 1977, 6: 303–309.

    Google Scholar 

  17. Hoppe JE, Schlagenhauf M: Comparison of three kinds of blood and two incubation atmospheres for cultivation ofBordetella pertussis on charcoal agar. Journal of Clinical Microbiology 1989, 27: 2115–2117.

    Google Scholar 

  18. Ewanowich CA, Chui LWL, Paranchych MG, Peppler MS, Marusyk RG, Albritton WL: Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. Journal of Clinical Microbiology 1993, 31: 1715–1725.

    Google Scholar 

  19. Meade BD, Bollen A: Recommendations for use of the polymerase chain reaction in the diagnosis ofBordetella pertussis infections. Journal of Medical Microbiology 1994, 41: 51–55.

    Google Scholar 

  20. Schläpfer G, Cherry JD, Heininger U, Überall M, Schmitt-Grohé S, Laussucq S, Just M, Stehr K: Polymerase chain reaction identification ofBordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany. Pediatric Infectious Disease Journal 1995, 14: 209–214.

    Google Scholar 

  21. Winsnes R: Serological responses to pertussis. In: Wardlaw AC, Parton R (ed): Pathogenesis and immunity in pertussis. J. Wiley, Chichester, 1988, p. 284–307.

    Google Scholar 

  22. Meade BD, Mink CM, Manclark CR: Serodiagnosis of pertussis. In: Manclark CR (ed): Proceedings of the 6th International Symposium on Pertussis. Department of Health and Human Services, United States Public Health Service, Bethesda, MD. DHHD Publication No. (FDA) 90-1164, 1990, p. 322–329.

    Google Scholar 

  23. Granström G, Wretlind B, Salenstedt CR, Granström M: Evaluation of serologic assays for diagnosis of whooping cough. Journal of Clinical Microbiology 1988, 26: 1818–1823.

    Google Scholar 

  24. Mertsola J, Ruuskanen O, Kuronen T, Meurman O, Viljanen MK: Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. Journal of Infectious Diseases 1990, 161: 966–971.

    Google Scholar 

  25. He Q, Mertsola J, Himanen JP, Ruuskanen O, Viljanen MK: Evaluation of pooled and individual components ofBordetella pertussis as antigens in an enzyme immunoassay for diagnosis of pertussis. European Journal of Clinical Microbiology & Infectious Diseases 1993, 12: 690–695.

    Google Scholar 

  26. Lewis K, Saubolle MA, Tenover FC, Rudinsky MF, Barbour SD, Cherry JD: Pertussis caused by an erythromycin-resistant strain ofBordetella pertussis. Pediatric Infectious Disease Journal 1995, 14: 388–391.

    Google Scholar 

  27. Hoppe JE, Haug A: Antimicrobial susceptibility ofBordetella pertussis. Infection 1988, 16: 126–130.

    Google Scholar 

  28. Hoppe JE, Tschirner T: Comparison of media for agar dilution susceptibility testing ofBordetella pertussis andBordetella parapertussis. European Journal of Clinical Microbiology & Infectious Diseases 1995, 14: 775–779.

    Google Scholar 

  29. Hoppe JE, and the Erythromycin Study Group: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. Pediatric Infectious Disease Journal 1992, 11: 189–193.

    Google Scholar 

  30. Bergquist SO, Bernander S, Dahnsjö H, Sundelöf B: Etythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatric Infectious Disease Journal 1987, 6: 458–461.

    Google Scholar 

  31. Bass JW: Pertussis: current status of prevention and treatment. Pediatric Infectious Disease 1985, 4: 614–619.

    Google Scholar 

  32. Trollfors B: Whooping cough — aspects of pathogenesis and treatment. Acta Otolaryngologica 1984, Supplement 407: 33–39.

    Google Scholar 

  33. Henry R, Dorman D, Skinner J, Mellis C: Limitations of erythromycin in whooping cough. Medical Journal of Australia 1981, 2: 108–109.

    Google Scholar 

  34. Sprauer MA, Cochi SL, Zell ER, Sutter RW, Mullen JR, Englender SJ, Partriarca PA: Prevention of secondary transmission of pertussis in households with early use of erythromycin. American Journal of Diseases of Children 1992, 146: 177–181.

    Google Scholar 

  35. Granström G, Sterner G, Nord CE, Granström M: Use of erythromycin to prevent pertussis in newborns of mothers with pertussis. Journal of Infectious Diseases 1987, 155: 1210–1214.

    Google Scholar 

  36. Hoppe JE, Haug A: Treatment and prevention of pertussis by antimicrobial agents. Infection 1988, 16: 148–152.

    Google Scholar 

  37. Hoppe JE, Eichhorn A: Activity of new macrolides againstBordetella pertussis andBordetella parapertussis. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 653–654.

    Google Scholar 

  38. Kurzynski TA, Boehm DM, Rott-Petri JA, Schell RF, Allison PE: Antimicrobial susceptibilities ofBordetella species isolated in a multicenter pertussis surveillance project. Antimicrobial Agents and Chemotherapy 1988, 32: 137–140.

    Google Scholar 

  39. Hoppe JE: Die Rolle der Makrolidantibiotika bei der Keuchhusten-Behandlung. Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie 1990, 9: 89–93.

    Google Scholar 

  40. Peters DH, Friedel HA, McTavish D: Azithromycin. Drugs 1992, 44: 750–799.

    Google Scholar 

  41. Henry RL, Dorman DC, Skinner JA, Mellis CM: Antimicrobial therapy in whooping cough. Medical Journal of Australia 1981, 2: 27–28.

    Google Scholar 

  42. Hoppe JE, Halm U, Hagedorn HJ, Kraminer-Hagedorn A: Comparison of erythromycin ethylsuccinate and cotrimoxazole for treatment of pertussis. Infection 1989, 17: 227–231.

    Google Scholar 

  43. Hoppe JE, Simon CG: In vitro susceptibilities ofBordetella pertussis andBordetella parapertussis to seven fluoroquinolones. Antimicrobial Agents and Chemotherapy 1990, 34: 2287–2288.

    Google Scholar 

  44. Appleman ME, Hadfield TL, Gaines JK, Winn RE: Susceptibility ofBordetella pertussis to five quinolone antimicrobic drugs. Diagnostic Microbiology and Infectious Disease 1987, 8: 131–133.

    Google Scholar 

  45. Wolfson JS: Quinolone antimicrobial agents: adverse effects and bacterial resistance. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 1080–1092.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Bacteriology, University Children's Hospital, Rümelinstrasse 23, 72070, Tübingen, Germany

    J. E. Hoppe

Authors
  1. J. E. Hoppe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoppe, J.E. Update on epidemiology, diagnosis, and treatment of pertussis. Eur. J. Clin. Microbiol. Infect. Dis. 15, 189–193 (1996). https://doi.org/10.1007/BF01591352

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01591352

Search

Navigation